APA (7th ed.) Citation

Kropff, M., Hillengaß, J., & Möhler, T. (2012). Thalidomide versus dexamethasone for the treatment of relapsed and/or refractory multiple myeloma: Results from OPTIMUM, a randomized trial. Haematologica, the hematology journal, 97(5), . https://doi.org/10.3324/haematol.2011.044271

Chicago Style (17th ed.) Citation

Kropff, Martin, Jens Hillengaß, and Thomas Möhler. "Thalidomide Versus Dexamethasone for the Treatment of Relapsed And/or Refractory Multiple Myeloma: Results from OPTIMUM, a Randomized Trial." Haematologica, the Hematology Journal 97, no. 5 (2012). https://doi.org/10.3324/haematol.2011.044271.

MLA (9th ed.) Citation

Kropff, Martin, et al. "Thalidomide Versus Dexamethasone for the Treatment of Relapsed And/or Refractory Multiple Myeloma: Results from OPTIMUM, a Randomized Trial." Haematologica, the Hematology Journal, vol. 97, no. 5, 2012, https://doi.org/10.3324/haematol.2011.044271.